ASPIRE BIOPHARMA HOLDINGS, INC. Diluted Shares Outstanding (Weighted Average)
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) reported Diluted Shares Outstanding (Weighted Average) of 1.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- ASPIRE BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.04M shares, a 2424.57% increase year-over-year.
- ASPIRE BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 156.69K shares, a 396.23% increase year-over-year.
- ASPIRE BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was -131.00M shares.
- ASPIRE BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 49.53M shares, a 79.43% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.04M shares 10-Q · filed 2026-08-13 | 599.71K shares 10-Q · filed 2026-08-13 | -43.27M shares derived: average of 3 quarters · filed 2026-08-13 | -20.07M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 156.69K shares 10-Q · filed 2026-05-15 | -65.42M shares derived: average of 2 quarters · filed 2026-05-15 | -27.10M shares derived: average of 3 quarters · filed 2026-05-15 | -20.32M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -131.00M shares derived: S-1/A 12 month − 10-Q 9 month · filed 2026-04-10 | -40.74M shares derived: average of 2 quarters · filed 2026-04-10 | -27.14M shares derived: average of 3 quarters · filed 2026-08-13 | 1.49M shares S-1/A · filed 2026-04-10 |
| 2025-09-30 | 49.53M shares 10-Q · filed 2025-11-14 | 24.78M shares derived: average of 2 quarters · filed 2026-08-13 | 45.66M shares 10-Q · filed 2025-11-14 | -7.61M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 41.11K shares 10-Q · filed 2026-08-13 | 36.41K shares 10-Q · filed 2026-08-13 | -26.65M shares derived: average of 3 quarters · filed 2026-08-13 | -13.09M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 31.57K shares 10-Q · filed 2026-05-15 | -40.00M shares derived: average of 2 quarters · filed 2026-05-15 | -17.46M shares derived: average of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | -80.03M shares derived: S-1/A 12 month − 10-Q 9 month · filed 2026-04-10 | -26.21M shares derived: average of 2 quarters · filed 2026-04-10 | 689.91K shares S-1/A · filed 2026-04-10 | |
| 2024-09-30 | 27.60M shares 10-Q · filed 2025-11-14 | 27.60M shares 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |